nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Emotional disorder—Varenicline—nicotine dependence	0.0372	0.0801	CcSEcCtD
Quinidine barbiturate—Night blindness—Varenicline—nicotine dependence	0.0345	0.0742	CcSEcCtD
Quinidine barbiturate—GABRA2—GABA A receptor activation—GABRA4—nicotine dependence	0.0204	0.048	CbGpPWpGaD
Quinidine barbiturate—GABRA1—GABA A receptor activation—GABRA4—nicotine dependence	0.0174	0.0409	CbGpPWpGaD
Quinidine barbiturate—Suicide—Varenicline—nicotine dependence	0.0157	0.0337	CcSEcCtD
Quinidine barbiturate—KCNK1—cardiovascular system—nicotine dependence	0.0151	0.147	CbGeAlD
Quinidine barbiturate—Completed suicide—Varenicline—nicotine dependence	0.0138	0.0297	CcSEcCtD
Quinidine barbiturate—GABRA2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.0125	0.0294	CbGpPWpGaD
Quinidine barbiturate—KCNK1—midbrain—nicotine dependence	0.0118	0.115	CbGeAlD
Quinidine barbiturate—Suicidal ideation—Varenicline—nicotine dependence	0.0116	0.0249	CcSEcCtD
Quinidine barbiturate—Nystagmus—Varenicline—nicotine dependence	0.0114	0.0245	CcSEcCtD
Quinidine barbiturate—Scotoma—Varenicline—nicotine dependence	0.0107	0.023	CcSEcCtD
Quinidine barbiturate—GABRA1—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.0106	0.025	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—CHRNB3—nicotine dependence	0.0106	0.025	CbGpPWpGaD
Quinidine barbiturate—Mydriasis—Varenicline—nicotine dependence	0.0102	0.0219	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—CHRNA6—nicotine dependence	0.0101	0.0237	CbGpPWpGaD
Quinidine barbiturate—GRIA2—midbrain—nicotine dependence	0.0096	0.0933	CbGeAlD
Quinidine barbiturate—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00938	0.0221	CbGpPWpGaD
Quinidine barbiturate—SCN5A—cardiovascular system—nicotine dependence	0.00902	0.0877	CbGeAlD
Quinidine barbiturate—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00899	0.0194	CcSEcCtD
Quinidine barbiturate—Thinking abnormal—Varenicline—nicotine dependence	0.00887	0.0191	CcSEcCtD
Quinidine barbiturate—Phenobarbital—CHRNA4—nicotine dependence	0.00836	1	CrCbGaD
Quinidine barbiturate—Nightmare—Varenicline—nicotine dependence	0.00784	0.0169	CcSEcCtD
Quinidine barbiturate—CHRM2—cardiovascular system—nicotine dependence	0.00768	0.0747	CbGeAlD
Quinidine barbiturate—Photophobia—Varenicline—nicotine dependence	0.00762	0.0164	CcSEcCtD
Quinidine barbiturate—Oesophagitis—Varenicline—nicotine dependence	0.00742	0.016	CcSEcCtD
Quinidine barbiturate—KCNK1—brain—nicotine dependence	0.00741	0.0721	CbGeAlD
Quinidine barbiturate—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00732	0.0172	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—GABRA4—nicotine dependence	0.00728	0.0172	CbGpPWpGaD
Quinidine barbiturate—Mental disability—Varenicline—nicotine dependence	0.00705	0.0152	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—CHRNB4—nicotine dependence	0.00698	0.0164	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00665	0.0157	CbGpPWpGaD
Quinidine barbiturate—GABRA2—GABA receptor activation—GABRA4—nicotine dependence	0.00662	0.0156	CbGpPWpGaD
Quinidine barbiturate—Deafness—Varenicline—nicotine dependence	0.00659	0.0142	CcSEcCtD
Quinidine barbiturate—Disorientation—Varenicline—nicotine dependence	0.00659	0.0142	CcSEcCtD
Quinidine barbiturate—Eczema—Varenicline—nicotine dependence	0.00656	0.0141	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—CHRNA5—nicotine dependence	0.00649	0.0153	CbGpPWpGaD
Quinidine barbiturate—Renal failure acute—Varenicline—nicotine dependence	0.00638	0.0137	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.0063	0.0148	CbGpPWpGaD
Quinidine barbiturate—Visual disturbance—Varenicline—nicotine dependence	0.00622	0.0134	CcSEcCtD
Quinidine barbiturate—Hypoglycaemia—Varenicline—nicotine dependence	0.00604	0.013	CcSEcCtD
Quinidine barbiturate—GRIA2—brain—nicotine dependence	0.00603	0.0587	CbGeAlD
Quinidine barbiturate—GABRA1—midbrain—nicotine dependence	0.00603	0.0586	CbGeAlD
Quinidine barbiturate—Lethargy—Varenicline—nicotine dependence	0.00601	0.013	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00597	0.0141	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00581	0.0137	CbGpPWpGaD
Quinidine barbiturate—Affect lability—Varenicline—nicotine dependence	0.0058	0.0125	CcSEcCtD
Quinidine barbiturate—GABRA1—GABA receptor activation—GABRA4—nicotine dependence	0.00564	0.0133	CbGpPWpGaD
Quinidine barbiturate—Irritability—Varenicline—nicotine dependence	0.00563	0.0121	CcSEcCtD
Quinidine barbiturate—Mood swings—Varenicline—nicotine dependence	0.00558	0.012	CcSEcCtD
Quinidine barbiturate—KCNH2—cardiovascular system—nicotine dependence	0.00554	0.0539	CbGeAlD
Quinidine barbiturate—Liver function test abnormal—Varenicline—nicotine dependence	0.00544	0.0117	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Varenicline—nicotine dependence	0.00538	0.0116	CcSEcCtD
Quinidine barbiturate—Breast disorder—Varenicline—nicotine dependence	0.00533	0.0115	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—CHRNA3—nicotine dependence	0.00529	0.0125	CbGpPWpGaD
Quinidine barbiturate—Asthma—Varenicline—nicotine dependence	0.00509	0.011	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Varenicline—nicotine dependence	0.00496	0.0107	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00474	0.0112	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—CHRNB2—nicotine dependence	0.00466	0.011	CbGpPWpGaD
Quinidine barbiturate—Photosensitivity reaction—Varenicline—nicotine dependence	0.00465	0.01	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0045	0.0097	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00449	0.0106	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00444	0.0105	CbGpPWpGaD
Quinidine barbiturate—SCN5A—brain—nicotine dependence	0.00442	0.043	CbGeAlD
Quinidine barbiturate—KCNH2—midbrain—nicotine dependence	0.00433	0.0421	CbGeAlD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00432	0.0102	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—CHRNA4—nicotine dependence	0.00423	0.00996	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00421	0.00991	CbGpPWpGaD
Quinidine barbiturate—Bradycardia—Varenicline—nicotine dependence	0.00415	0.00894	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00414	0.00975	CbGpPWpGaD
Quinidine barbiturate—Hallucination—Varenicline—nicotine dependence	0.00406	0.00874	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Varenicline—nicotine dependence	0.00403	0.00867	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Varenicline—nicotine dependence	0.004	0.00861	CcSEcCtD
Quinidine barbiturate—Visual impairment—Varenicline—nicotine dependence	0.00393	0.00846	CcSEcCtD
Quinidine barbiturate—GABRA2—brain—nicotine dependence	0.00392	0.0381	CbGeAlD
Quinidine barbiturate—GABRA2—Orphan transporters—GABRA4—nicotine dependence	0.00386	0.00909	CbGpPWpGaD
Quinidine barbiturate—Erythema multiforme—Varenicline—nicotine dependence	0.00386	0.0083	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00385	0.00907	CbGpPWpGaD
Quinidine barbiturate—Eye disorder—Varenicline—nicotine dependence	0.00381	0.00821	CcSEcCtD
Quinidine barbiturate—Tinnitus—Varenicline—nicotine dependence	0.0038	0.00819	CcSEcCtD
Quinidine barbiturate—GABRA1—brain—nicotine dependence	0.00379	0.0368	CbGeAlD
Quinidine barbiturate—Cardiac disorder—Varenicline—nicotine dependence	0.00378	0.00815	CcSEcCtD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00378	0.00891	CbGpPWpGaD
Quinidine barbiturate—CHRM2—brain—nicotine dependence	0.00377	0.0366	CbGeAlD
Quinidine barbiturate—Immune system disorder—Varenicline—nicotine dependence	0.00368	0.00793	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Varenicline—nicotine dependence	0.00367	0.00791	CcSEcCtD
Quinidine barbiturate—Chills—Varenicline—nicotine dependence	0.00366	0.00788	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—CHRNB3—nicotine dependence	0.00363	0.00855	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00359	0.00845	CbGpPWpGaD
Quinidine barbiturate—Mental disorder—Varenicline—nicotine dependence	0.00357	0.00769	CcSEcCtD
Quinidine barbiturate—Malnutrition—Varenicline—nicotine dependence	0.00355	0.00764	CcSEcCtD
Quinidine barbiturate—Erythema—Varenicline—nicotine dependence	0.00355	0.00764	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00346	0.00815	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—CHRNA6—nicotine dependence	0.00344	0.0081	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00335	0.0079	CbGpPWpGaD
Quinidine barbiturate—Vision blurred—Varenicline—nicotine dependence	0.00335	0.0072	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00334	0.00786	CbGpPWpGaD
Quinidine barbiturate—Tremor—Varenicline—nicotine dependence	0.00333	0.00716	CcSEcCtD
Quinidine barbiturate—GABRA1—Orphan transporters—GABRA4—nicotine dependence	0.00329	0.00775	CbGpPWpGaD
Quinidine barbiturate—Agitation—Varenicline—nicotine dependence	0.00326	0.00703	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00325	0.00765	CbGpPWpGaD
Quinidine barbiturate—Angioedema—Varenicline—nicotine dependence	0.00324	0.00699	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00321	0.00755	CbGpPWpGaD
Quinidine barbiturate—Vertigo—Varenicline—nicotine dependence	0.00319	0.00687	CcSEcCtD
Quinidine barbiturate—Syncope—Varenicline—nicotine dependence	0.00318	0.00686	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00316	0.00745	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00314	0.00739	CbGpPWpGaD
Quinidine barbiturate—Palpitations—Varenicline—nicotine dependence	0.00314	0.00676	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Varenicline—nicotine dependence	0.00312	0.00672	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00311	0.00733	CbGpPWpGaD
Quinidine barbiturate—Convulsion—Varenicline—nicotine dependence	0.00308	0.00662	CcSEcCtD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00305	0.00719	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00304	0.00716	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.00304	0.00716	CbGpPWpGaD
Quinidine barbiturate—Arthralgia—Varenicline—nicotine dependence	0.00302	0.00651	CcSEcCtD
Quinidine barbiturate—Myalgia—Varenicline—nicotine dependence	0.00302	0.00651	CcSEcCtD
Quinidine barbiturate—Chest pain—Varenicline—nicotine dependence	0.00302	0.00651	CcSEcCtD
Quinidine barbiturate—Anxiety—Varenicline—nicotine dependence	0.00301	0.00649	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.003	0.00646	CcSEcCtD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00292	0.00687	CbGpPWpGaD
Quinidine barbiturate—Oedema—Varenicline—nicotine dependence	0.0029	0.00624	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00289	0.00682	CbGpPWpGaD
Quinidine barbiturate—Shock—Varenicline—nicotine dependence	0.00285	0.00614	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00284	0.0067	CbGpPWpGaD
Quinidine barbiturate—Nervous system disorder—Varenicline—nicotine dependence	0.00284	0.00612	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Varenicline—nicotine dependence	0.00284	0.00611	CcSEcCtD
Quinidine barbiturate—Tachycardia—Varenicline—nicotine dependence	0.00283	0.00609	CcSEcCtD
Quinidine barbiturate—Skin disorder—Varenicline—nicotine dependence	0.00281	0.00606	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Varenicline—nicotine dependence	0.0028	0.00603	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00276	0.00651	CbGpPWpGaD
Quinidine barbiturate—Anorexia—Varenicline—nicotine dependence	0.00276	0.00595	CcSEcCtD
Quinidine barbiturate—KCNH2—brain—nicotine dependence	0.00272	0.0265	CbGeAlD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00271	0.00638	CbGpPWpGaD
Quinidine barbiturate—Hypotension—Varenicline—nicotine dependence	0.00271	0.00583	CcSEcCtD
Quinidine barbiturate—GABRA2—Ion channel transport—GABRA4—nicotine dependence	0.00271	0.00637	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0027	0.00635	CbGpPWpGaD
Quinidine barbiturate—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00264	0.00568	CcSEcCtD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00259	0.00611	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Varenicline—nicotine dependence	0.00258	0.00556	CcSEcCtD
Quinidine barbiturate—Somnolence—Varenicline—nicotine dependence	0.00258	0.00555	CcSEcCtD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00256	0.00604	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNB3—nicotine dependence	0.00256	0.00602	CbGpPWpGaD
Quinidine barbiturate—Decreased appetite—Varenicline—nicotine dependence	0.00252	0.00542	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00251	0.00591	CbGpPWpGaD
Quinidine barbiturate—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0025	0.00539	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—GABRA4—nicotine dependence	0.00249	0.00586	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00249	0.00586	CbGpPWpGaD
Quinidine barbiturate—Constipation—Varenicline—nicotine dependence	0.00248	0.00534	CcSEcCtD
Quinidine barbiturate—Pain—Varenicline—nicotine dependence	0.00248	0.00534	CcSEcCtD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNA6—nicotine dependence	0.00242	0.00571	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00241	0.00569	CbGpPWpGaD
Quinidine barbiturate—Feeling abnormal—Varenicline—nicotine dependence	0.00239	0.00514	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—CHRNB4—nicotine dependence	0.00239	0.00562	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00238	0.00561	CbGpPWpGaD
Quinidine barbiturate—Gastrointestinal pain—Varenicline—nicotine dependence	0.00237	0.0051	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00236	0.00556	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00235	0.00554	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00231	0.00544	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00231	0.00544	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Ion channel transport—GABRA4—nicotine dependence	0.00231	0.00544	CbGpPWpGaD
Quinidine barbiturate—Urticaria—Varenicline—nicotine dependence	0.0023	0.00496	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Varenicline—nicotine dependence	0.00229	0.00493	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Varenicline—nicotine dependence	0.00229	0.00493	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00229	0.00539	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00228	0.00537	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00224	0.00527	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—CHRNA5—nicotine dependence	0.00222	0.00522	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00221	0.0052	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.0022	0.00518	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00219	0.00516	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNB3—nicotine dependence	0.00218	0.00513	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Varenicline—nicotine dependence	0.00213	0.0046	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.00211	0.00496	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0021	0.00494	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00208	0.0049	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Varenicline—nicotine dependence	0.00208	0.00448	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00208	0.00489	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNA6—nicotine dependence	0.00207	0.00487	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Varenicline—nicotine dependence	0.00205	0.00441	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00204	0.0048	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00203	0.00479	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Varenicline—nicotine dependence	0.00198	0.00427	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00196	0.00461	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00196	0.00461	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00195	0.00459	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00195	0.00458	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Varenicline—nicotine dependence	0.00192	0.00413	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00189	0.00444	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00188	0.00444	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00187	0.0044	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Varenicline—nicotine dependence	0.00184	0.00397	CcSEcCtD
Quinidine barbiturate—Rash—Varenicline—nicotine dependence	0.00183	0.00393	CcSEcCtD
Quinidine barbiturate—Dermatitis—Varenicline—nicotine dependence	0.00182	0.00393	CcSEcCtD
Quinidine barbiturate—Headache—Varenicline—nicotine dependence	0.00181	0.00391	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—CHRNA3—nicotine dependence	0.00181	0.00426	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00178	0.0042	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00177	0.00416	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GABRA4—nicotine dependence	0.00175	0.00413	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00174	0.00409	CbGpPWpGaD
Quinidine barbiturate—Nausea—Varenicline—nicotine dependence	0.00172	0.00371	CcSEcCtD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNB4—nicotine dependence	0.00168	0.00396	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00166	0.00391	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—brain—nicotine dependence	0.00166	0.0161	CbGeAlD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00166	0.00391	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.0016	0.00376	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—CHRNB2—nicotine dependence	0.00159	0.00375	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNA5—nicotine dependence	0.00156	0.00368	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00152	0.00358	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00151	0.00355	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GABRA4—nicotine dependence	0.00149	0.00352	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00146	0.00345	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00146	0.00344	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—CHRNA4—nicotine dependence	0.00145	0.0034	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNB4—nicotine dependence	0.00143	0.00337	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00142	0.00334	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.00141	0.00331	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.0014	0.00331	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00138	0.00325	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNA5—nicotine dependence	0.00133	0.00314	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00133	0.00313	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.00128	0.00301	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNA3—nicotine dependence	0.00127	0.003	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00126	0.00297	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00125	0.00294	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00119	0.00281	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00113	0.00267	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNB2—nicotine dependence	0.00112	0.00264	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0011	0.0026	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNA3—nicotine dependence	0.00109	0.00256	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00108	0.00255	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00104	0.00245	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00103	0.00242	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNA4—nicotine dependence	0.00102	0.0024	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNB2—nicotine dependence	0.000956	0.00225	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000942	0.00222	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000878	0.00207	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNA4—nicotine dependence	0.000868	0.00204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000814	0.00192	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000803	0.00189	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000712	0.00168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000698	0.00164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000647	0.00152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000634	0.00149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000589	0.00139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000559	0.00132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000531	0.00125	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000508	0.0012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000504	0.00119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000384	0.000905	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000382	0.0009	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.0003	0.000707	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.0003	0.000706	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000273	0.000642	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000265	0.000624	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000217	0.000511	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000197	0.000464	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000187	0.00044	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000179	0.000421	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000178	0.000419	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000161	0.000379	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000116	0.000274	CbGpPWpGaD
